A Study to Compare Two Dosing Regimens for a New Malaria Vaccine

NCT06141057 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

24

Enrollment

OTHER

Sponsor class

Conditions

Malaria
Malaria,Falciparum
Protozoan Infections
Parasitic Disease
Infections
Vector Borne Diseases

Interventions

BIOLOGICAL: Matrix M with RH5.1

Sponsor

University of Oxford